Evaluation of glucosamine coated mesoporous silica nanoparticles for antioxidant activity cytocompatibility and blood brain barrier permeability in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) remains a fatal neurodegenerative disease with limited disease-modifying options, and effective delivery of therapeutics to the central nervous system is hindered by the blood–brain barrier (BBB). Here, we report mesoporous silica nanoparticles (MSNs) designed as a combination-delivery platform integrating riluzole, 5-methoxytryptamine (5MT) as an antioxidant-related component, and glucosamine as a biomolecular surface coating. The resulting multifunctional nanosystems were prepared and characterized by complementary physicochemical techniques, supporting successful incorporation of the selected components within the MSN-based carrier. To obtain a first-pass indication of brain-oriented delivery feasibility, permeability was assessed using a PAMPA-BBB assay that mimics key features of the brain lipid environment. This screening assay showed formulation-dependent apparent silica carryover across the artificial lipid membrane and provides a basis for subsequent evaluation in cell-based BBB models, supporting their further evaluation as ALS-oriented nanodelivery candidates. Overall, these results establish a rational proof-of concept of MSN platform for combination delivery and provide a permeability-screening basis for subsequent studies in more advanced BBB and neurobiological models, supporting their further evaluation as multifunctional delivery platforms for neurodegenerative diseases, such as ALS.
Authors
- Victoria García‐Almodóvar (ORCID: https://orcid.org/0000-0003-2609-7683)
- Santiago Gómez‐Ruiz (ORCID: https://orcid.org/0000-0001-9538-8359)
- Diana Díaz‐García (ORCID: https://orcid.org/0000-0003-3057-4905)
- Nagore Grasa-Gude (ORCID: https://orcid.org/0009-0003-2505-9869)
Institutions
- Universidad Rey Juan Carlos (ES)
Publication Details
- Journal
- Discover Nano
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1186/s11671-026-05075-7
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00